Walleye Capital
ATRS

Walleye Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Walleye Capital’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-82,000
Closed -$336K – 2881
2022
Q1 		$336K Buy
+82,000
New +$297K 0.01% 1243

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's ATRS Position: Q2 2022 in Review

Walleye Capital sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 82,000 shares — an estimated $336K sold.

Walleye Capital first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $336K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Walleye Capital reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Walleye Capital sold 82,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $336K.
  • Walleye Capital first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Walleye Capital's Antares Pharma, Inc. position peaked at $336K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Walleye Capital's 13F filing for Q2 2022, filed 8 Aug 2022.